Cognition-enhancing effects of moclobemide, a reversible MAO inhibitor, in humans
Anand, R.; Wesnes, K.A.
Advances in Neurology 51: 261-268
1990
ISSN/ISBN: 0091-3952 PMID: 2294659 Document Number: 349478
Document emailed within 1 workday
Related Documents
Wesnes, K.A.; Simpson, P.M.; Christmas, L.; Anand, R.; McClelland, G.R. 1989: The effects of moclobemide on cognition Journal of Neural Transmission. Supplementum 28: 91-102Schläppi, B. 1985: The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid Arzneimittel-Forschung 35(5): 800-803
Petkov, V.D.; Mosharrof, A.H. 1989: Memory effects of the new derivative of the p-chlorophenoxyacetic acid adafenoxate compared to the effects of some cognition-enhancing drugs in rats Arzneimittel-Forschung 39(9): 1133-1136
Haefely, W.E.; Kettler, R.; Keller, H.H.; Da Prada, M. 1990: Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans Advances in Neurology 53: 505-512
Hooks, W.N.; Colman, K.A.; Gopinath, C.; Inage, F.; Kato, M.; Takayama, S. 1994: Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats Arzneimittel-Forschung 44(2a): 220-228
Tiller, J.W.; Bouwer, C.; Behnke, K. 1997: Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder International Clinical Psychopharmacology 12(Suppl 6): S27-S30
Shaw, K.P.; Aracava, Y.; Akaike, A.; Daly, J.W.; Rickett, D.L.; Albuquerque, E.X. 1985: The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex Molecular Pharmacology 28(6): 527-538
Salas, E.; Rosen, M.A.; Burke, C.Shawn.; Nicholson, D.; Howse, W.R. 2007: Markers for enhancing team cognition in complex environments: the power of team performance diagnosis Aviation Space and Environmental Medicine 78(5 Suppl): B77-B85
Thomas, S.V.; Somanathan, N.; Rao, V.R.; Radhakurmari, K. 1996: Reversible non enhancing lesions without focal neurological deficits in eclampsia Indian Journal of Medical Research 103: 94-97
Menkes, D.B.; Wood, K.; Wooods, D. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 476
Fahy, T.J. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 475-476
Nowakowska, E.; Chodera, A.; Kus, K.; Rybakowski, J. 1998: Anxiolytic and memory improving effects of moclobemide Arzneimittel-Forschung 48(6): 625-628
Górka, Z.; Zajaczkowski, W. 1991: Light-dark phase differences in behavioral effects of moclobemide in rats Polish Journal of Pharmacology and Pharmacy 43(3): 177-186
Coquoz, D.; Porchet, H.C.; Dayer, P. 1991: Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide Schweizerische Medizinische Wochenschrift 121(49): 1843-1845
Kagaya, T.; Kajiwara, A.; Nagato, S.; Akasaka, K.; Kubota, A. 1996: E2011 a novel, selective and reversible inhibitor of monoamine oxidase type a Journal of Pharmacology and Experimental Therapeutics 278(1): 243-251
Kim, S.H.; Han, K.S.; Choi, W.S.; Chang, M.S.; Lee, M.G. 1997: Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1 Research Communications in Molecular Pathology and Pharmacology 98(1): 77-84
MacFarlane, M.D. 1975: Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase Federation Proceedings 34(1): 108-110
Khan, N.A.; Havouis, R.; Quemener, V.; Moulinoux, J.P. 1992: Protein kinase C inhibitor (H-7) potentiates antiproliferative effects of a polyamine biosynthesis inhibitor Anticancer Research 12(4): 1223-1226
Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Bandhu, R.; Shankar, N.; Tandon, O.P.; Madan, N. 2003: Effects of iron therapy on cognition in anemic school going boys Indian Journal of Physiology and Pharmacology 47(3): 301-310